The era of gene therapy has arrived. Our mission at Kriya Therapeutics is to expand the reach of gene therapy to address highly prevalent and serious diseases affecting millions of patients. Kriya is a next-generation gene therapy company focused on designing and developing transformative new treatments for highly prevalent and severe chronic diseases.

Profile

Social Media

Kriya Therapeutics Company Twitter Account

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chairman

Roger Jeffs

Chief Executive Officer

Shankar Ramaswamy

Chief Financial Officer

Daniel Chen

Chief Medical Officer

Ilise Lombardo

Chief Technical Officer

Nachi Gupta

Co-Founder

Fraser Wright

Controller

Amy Chen

Vice President

Ashlyn Bassiri

Vice President

Erik Hughes

Vice President

Mitch Lower

Vice President

Jason Mallory

Vice President

Zhu Pirot

Vice President

Joseph Rabinowitz

Vice President

Stephen Soltys

Vice President

Michele Stone

Vice President

Wayne Yount

VP - Administration

Lily Nguyen

VP - Bus. Development

Melissa Rhodes

VP - General Counsel

Dana Johnson

VP - Manufacturing

Britt Petty

VP - Regulatory Affairs

Harold Alterson

VP - Regulatory Affairs

Brian Furmanski

Browse more venture capital transactions:

Prev: 5/14/2020: ALTR venture capital transaction
Next: 5/14/2020: DispatchTrack venture capital transaction

Share this article

Where The Data Comes From

We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary